ID

38111

Descripción

Study ID: 105036 Clinical Study ID: 105036 Study Title: A single-blind, randomized, placebo-controlled study to investigate the safety, tolerability, and potential effects on betamethasone pharmacokinetics of a co-administered infusion of GSK221149A in healthy female subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: betamethasone Trade Name: Retosiban Study Indication: Women's Health & Pregnancy - Other, pre-term labour

Palabras clave

Versiones (1)
  1. 18/9/19 18/9/19 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

18 de septiembre de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Betamethasone pharmacokinetics of a co-administered infusion of GSK221149A; 105036

Inglés

Pharmacokinetics Blood

1 formularios  
  1. StudyEvent: ODM
    1. Pharmacokinetics Blood
Dosing Date and Time
Descripción

Dosing Date and Time

Alias
UMLS CUI-1
C0031328
UMLS CUI-2
C0178602
UMLS CUI-3
C0011008
UMLS CUI-4
C0040223
Dosing date/time
Descripción

Pharmacokinetic aspects, Dosage, Date in time, Time

Tipo de datos

datetime

Alias
UMLS CUI [1,1]
C0031328
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0011008
UMLS CUI [1,4]
C0040223
Predose
Descripción

Predose

Alias
UMLS CUI-1
C0031328
UMLS CUI-2
C0439565
Actual time
Descripción

Pharmacokinetic aspects, Pre-dose, Time

Tipo de datos

time

Alias
UMLS CUI [1,1]
C0031328
UMLS CUI [1,2]
C0439565
UMLS CUI [1,3]
C0040223
0,5 Hour post dose
Descripción

0,5 Hour post dose

Alias
UMLS CUI-1
C0031328
UMLS CUI-2
C0439568
UMLS CUI-3
C1442458
Actual time
Descripción

Pharmacokinetic aspects, Post-dose, 30 Minutes , Time

Tipo de datos

time

Alias
UMLS CUI [1,1]
C0031328
UMLS CUI [1,2]
C0439568
UMLS CUI [1,3]
C1442458
UMLS CUI [1,4]
C0040223
6 Hours post dose
Descripción

6 Hours post dose

Alias
UMLS CUI-1
C0031328
UMLS CUI-2
C0439568
UMLS CUI-3
C1292428
Actual time
Descripción

Pharmacokinetic aspects, Post-dose, 6 Hours, Time

Tipo de datos

time

Alias
UMLS CUI [1,1]
C0031328
UMLS CUI [1,2]
C0439568
UMLS CUI [1,3]
C1292428
UMLS CUI [1,4]
C0040223
12 Hours post dose
Descripción

12 Hours post dose

Alias
UMLS CUI-1
C0031328
UMLS CUI-2
C0439568
UMLS CUI-3
C1292430
Actual time
Descripción

Pharmacokinetic aspects, Post-dose, 12 Hours, Time

Tipo de datos

time

Alias
UMLS CUI [1,1]
C0031328
UMLS CUI [1,2]
C0439568
UMLS CUI [1,3]
C1292430
UMLS CUI [1,4]
C0040223
24 Hours post dose
Descripción

24 Hours post dose

Alias
UMLS CUI-1
C0031328
UMLS CUI-2
C0439568
UMLS CUI-3
C1442770
Actual time
Descripción

Pharmacokinetic aspects, Post-dose, 24 Hours, Time

Tipo de datos

time

Alias
UMLS CUI [1,1]
C0031328
UMLS CUI [1,2]
C0439568
UMLS CUI [1,3]
C1442770
UMLS CUI [1,4]
C0040223
Volver a la parte superior de la página

Similar models

Pharmacokinetics Blood

1 formularios
  1. StudyEvent: ODM
    1. Pharmacokinetics Blood
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Dosing Date and Time
C0031328 (UMLS CUI-1)
C0178602 (UMLS CUI-2)
C0011008 (UMLS CUI-3)
C0040223 (UMLS CUI-4)
Pharmacokinetic aspects, Dosage, Date in time, Time
Item
Dosing date/time
datetime
C0031328 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
Item Group
Predose
C0031328 (UMLS CUI-1)
C0439565 (UMLS CUI-2)
Pharmacokinetic aspects, Pre-dose, Time
Item
Actual time
time
C0031328 (UMLS CUI [1,1])
C0439565 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,3])
Item Group
0,5 Hour post dose
C0031328 (UMLS CUI-1)
C0439568 (UMLS CUI-2)
C1442458 (UMLS CUI-3)
Pharmacokinetic aspects, Post-dose, 30 Minutes , Time
Item
Actual time
time
C0031328 (UMLS CUI [1,1])
C0439568 (UMLS CUI [1,2])
C1442458 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
Item Group
6 Hours post dose
C0031328 (UMLS CUI-1)
C0439568 (UMLS CUI-2)
C1292428 (UMLS CUI-3)
Pharmacokinetic aspects, Post-dose, 6 Hours, Time
Item
Actual time
time
C0031328 (UMLS CUI [1,1])
C0439568 (UMLS CUI [1,2])
C1292428 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
Item Group
12 Hours post dose
C0031328 (UMLS CUI-1)
C0439568 (UMLS CUI-2)
C1292430 (UMLS CUI-3)
Pharmacokinetic aspects, Post-dose, 12 Hours, Time
Item
Actual time
time
C0031328 (UMLS CUI [1,1])
C0439568 (UMLS CUI [1,2])
C1292430 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
Item Group
24 Hours post dose
C0031328 (UMLS CUI-1)
C0439568 (UMLS CUI-2)
C1442770 (UMLS CUI-3)
Pharmacokinetic aspects, Post-dose, 24 Hours, Time
Item
Actual time
time
C0031328 (UMLS CUI [1,1])
C0439568 (UMLS CUI [1,2])
C1442770 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial